DCOY
Financials
- Market Capitalization 1.9 M
- Employee 11
- Founded 2014
- CEO N/A
- Website www.decoytx.com
- Headquarter Delaware, United States
- FIGI BBG00740LLD5
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5018 |  PPCB Propanc Biopharma, Inc. - Common Stock | 1.35 USD | -39.46% | +19.47% | +35.00% | -54.85% | 3.08 M USD | ||
| 5039 |  VBIO Valion Bio, Inc. - Common stock | 0.12 USD | 0.00% | -14.29% | -55.56% | -90.00% | 2.66 M USD | ||
| 5229 |  AZN AstraZeneca PLC - American Depositary Shares | 162.70 USD | -1.10% | -1.14% | -4.47% | +103.73% | 0 USD | ||
| 5300 |  GRFS Grifols, S.A. - American Depositary Shares | 7.69 USD | -1.66% | -3.88% | -7.57% | -21.21% | 0 USD |
Frequently asked questions about Decoy Therapeutics Inc. Common Stock
What is the Decoy Therapeutics Inc. Common Stock stock price today?
The current price of Decoy Therapeutics Inc. Common Stock (DCOY) is 2.90. Over the past 24 hours, the stock has changed by -2.36%. Follow the DCOY chart for real-time price dynamics.
What is the stock ticker of Decoy Therapeutics Inc. Common Stock?
Decoy Therapeutics Inc. Common Stock trades under the ticker DCOY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Decoy Therapeutics Inc. Common Stock stock going up?
DCOY has changed by -9.94% over the last week, -30.46% over the last month, and +258.56% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Decoy Therapeutics Inc. Common Stock?
Decoy Therapeutics Inc. Common Stock currently has a market capitalization of 1.9 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Decoy Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Decoy Therapeutics Inc. Common Stock reported earnings of -4.46 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Decoy Therapeutics Inc. Common Stock revenue for the last quarter?
Decoy Therapeutics Inc. Common Stock reported quarterly revenue of 227.63 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Decoy Therapeutics Inc. Common Stock net income for the last quarter?
Decoy Therapeutics Inc. Common Stock reported net income of -2.37 M for the last quarter. The previous quarter showed -2.22 M, which means net income changed by -6.71%.
How many employees does Decoy Therapeutics Inc. Common Stock have?
As of the latest available data, Decoy Therapeutics Inc. Common Stock has 11 employees. Workforce size can provide additional context about the company's scale and operations.
What is Decoy Therapeutics Inc. Common Stock EBITDA?
Decoy Therapeutics Inc. Common Stock EBITDA is -2.39 M, and its EBITDA margin is -1 049.85%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Decoy Therapeutics Inc. Common Stock stock?
You can buy Decoy Therapeutics Inc. Common Stock (DCOY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Decoy Therapeutics Inc. Common Stock stock?
Investing in Decoy Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DCOY chart and related analysis on metatrader.com as part of your research.